Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi, OriGene Ink Assay Development, Marketing Pact

NEW YORK (GenomeWeb News) – Hitachi Software Engineering America and OriGene Technologies said after the close of the market on Friday that they have entered into a co-marketing agreement to jointly promote products for assay development.

Specifically, the firms will co-market OriGene's multiplex assays built on Luminex xMAP/Bio-Plex technology with Hitachi's MasterPlex software suite for analysis and reporting of multiplex assay data. As part of the deal, OriGene will use the MasterPlex software exclusively in all immunoassay and custom assay development, the firms said. Customers who purchase OriGene's assays will be offered the use of the MasterPlex software for 30 days, they added.

Among OriGene's products are multiplexed assays for microRNA expression, transcription factors profiling, and genotyping.

"Going forward, OriGene and Hitachi Software plan to leverage our new partnership to bring an even broader range of research and analysis solutions to our current and future life sciences customers," Robert Lynde, director of sales for Hitachi Software, said in a statement.

Financial and further terms of the alliance were not disclosed.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.